SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026663
Filing Date
2018-11-05
Accepted
2018-11-05 10:20:01
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-10q_20180930.htm 10-Q 1159963
2 EX-31.1 krys-ex311_7.htm EX-31.1 23531
3 EX-31.2 krys-ex312_8.htm EX-31.2 24132
4 EX-32.1 krys-ex321_6.htm EX-32.1 24109
  Complete submission text file 0001564590-18-026663.txt   5066286

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20180930.xml EX-101.INS 1145534
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20180930.xsd EX-101.SCH 38197
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20180930_cal.xml EX-101.CAL 32576
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20180930_def.xml EX-101.DEF 122538
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20180930_lab.xml EX-101.LAB 295458
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20180930_pre.xml EX-101.PRE 241380
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 181159087
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences